Ladies and gentlemen, thank you for standing by. Welcome to the 3M First Quarter Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded, Tuesday, April 21, 2026.
Management plans to file for regulatory approval of "Tresmi" for PAH and ILD this year, with commercial launch targeted for next year. Tyvaso DPI platform enhancement -- Introduction of 80-microgram ...
Background Native aortic valve endocarditis continues to present significant operative challenges, often complicated by heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results